Folic acid supplement study in pregnant women with thalassemia trait
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks at whether taking folic acid during pregnancy is beneficial for people who carry thalassemia trait. It may help guide safer supplement use during pregnancy, especially for lowering risks related to fetal development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one baby (not twins or more).
- You have alpha thalassemia trait or beta thalassemia trait.
- You are not already taking more than 0.6 mg folic acid daily for 3+ months during pregnancy.
- Your first antenatal (prenatal) visit happens at 16 weeks of pregnancy or less.
- You are between 18 and under the age limit (not 18 or younger).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if certain drugs can safely increase fetal hemoglobin (a type of hemoglobin that helps carry oxygen) in people with beta thalassemia major. It may offer a new way to manage the condition and reduce the need for transfusions.
This study tests a new medication called SNH-119014 to treat a type of thalassemia (an inherited blood disorder) in adults who don't regularly need blood transfusions. The goal is to see if this drug can improve your hemoglobin levels and reduce symptoms.
This trial tests whether two common antioxidants—N-acetyl cysteine and alpha lipoic acid—can help people with beta thalassemia. It aims to see if these supplements improve health outcomes when added to usual care.
This study tests if a higher dose of folic acid (a B vitamin) before pregnancy helps prevent certain birth defects. If you are trying to get pregnant and are generally healthy, you may be able to join.
This study looks at how a vitamin called tetrahydrofolate may affect pregnancies with preeclampsia or increased risk of high blood pressure. Participants may receive the supplement to help researchers understand key biology and potential benefits or harms.
This trial tests a treatment for iron deficiency anemia in pregnant women between 24 and 32 weeks. It aims to see if managing anemia improves health for both mother and baby.
Hear when a new Thalassemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.